Nationwide Initiation of Cardiovascular Risk Treatments During the COVID-19 Pandemic in France: Women on a Slippery Slope?

20228 citationsJournal Articlegold Open Access

Authors

A. Gabet · Santé Publique France

Clémence Grave · Institut de Veille Sanitaire

Philippe Tuppin · l'Assurance Maladie

Thomas Lesuffleur · Inserm

Charles Guénancia · Maison des Sciences de l’Homme de Dijon

Viêt Nguyen‐Thanh · Bicêtre Hospital

Romain Guignard ·

Abstract

The COVID-19 pandemic heavily impacted the initiation of medication treatments for cardiovascular risk in France, particularly in women and people over 65 years.

Topics & Keywords

COVID-19 Clinical Research Studies COVID-19 and healthcare impacts Health Systems, Economic Evaluations, Quality of Life

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Frontiers in Cardiovascular Medicine

Volume 9, pp. 856689-856689

DOI: 10.3389/fcvm.2022.856689

Field-Weighted Citation Impact: 0.71